About TRITON-TIMI 38The TRITON-TIMI 38 on on 13 PDE-5.

About TRITON-TIMI 38The TRITON-TIMI 38 on on 13,608 patients undergoing PCI with ACS. Compared with those treated with clopidogrel, reached the patient. PDE-5

The TRITON-TIMI 38 study a total of 10,074 patients with chest pain at rest or suffering from NSTEMI together.The study combined endpoint, the relative risk of cardiovascular death, non – fatal myocardial infarction or nonfatal stroke, patients treated with prasugrel will, a statistically significant 18 percent % reduction in risk compared with those who were administered clopidogrel. Patients2.2 percent of all participants of the patients developed prasugrel non – CABG-related TIMI major , compared with 1.6 percent of patients on clopidogrel, 3 percent and 1.6 percent of patients on the development of non – CABG – related TIMI smaller. Bleeding was significantly higher in patients treated with prasugrel vs. Clopidogrel.


Adjusted the body careful antigen stimulation level In If there is too little by which matter, risk of infection and cancers increases if there is too much IFNg is, NK cells arise to copious and autoimmune disorders such as inflammatory bowel disease. Can.

In addition, the researchers found to TGFb rotating down antigen stimulation production of – and thus NK cell activity – directly as well as indirect.

Related Articles

Other Articles from "psychology":